Prestwick3_000855

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers, 18 USDMF, 12 CEP/COS, 2 JDMF, 5 EU WC, 3 KDMF, 13 NDC API, 30 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

DOSSIERs // Finished Dosage Forms

136 Dossiers, 14 FDA Orange Book, 64 Europe, 7 Canada, 4 Australia, 15 South Africa, 32 Listed Dossiers

DRUG PRODUCT COMPOSITION

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 8 Sigachi Industries, 8 Roquette, 6 Microlex e.U, 6 Gangwal Chemicals, 6 Seppic, 6 Actylis, 5 Gangwal Healthcare, 4 Kerry, 2 DFE Pharma, 1 Pharmatrans-Sanaq, 1 Jai Radhe Sales, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Nanjing Bold Chemical, 1 Vasa Pharmachem, 1 Rochem International Inc, 1 Kima Chemical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Prachin Chemical, 1 BASF, 1 Nanjing Well Pharmaceutical, 1 SPI Pharma, 1 Finar, 1 The Dow Chemical Company, 1 Ideal Cures Pvt Ltd

EXCIPIENTS BY APPLICATIONS

16 Fillers, Diluents & Binders, 15 Solubilizers, 13 Thickeners and Stabilizers, 11 Direct Compression, 8 Co-Processed Excipients, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 6 Controlled & Modified Release, 5 Granulation, 4 Rheology Modifiers, 4 Coating Systems & Additives, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 3 Topical, 2 Chewable & Orodispersible Aids, 2 Lubricants & Glidants, 2 Taste Masking, 2 Surfactant & Foaming Agents, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 52 Finished Drug Prices

MARKET PLACE

13 APIs, 2 DOSSIERS // FDF, 1 EXCIPIENTS

PATENTS

48 US Patents, 2 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 1 USP Standards, 1 JP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 17 News

Prestwick3_000855
US Patents
Full Screen View

Information, Expiry & Status of FDA Orange Book Patents covering Prestwick3_000855

Prestwick3_000855

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers

18 USDMF

12 CEP/COS

2 JDMF

5 EU WC

3 KDMF

13 NDC API

30 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

DOSSIERs // Finished Dosage Forms

136 Dossiers

14 FDA Orange Book

64 Europe

7 Canada

4 Australia

15 South Africa

32 Listed Dossiers

DRUG PRODUCT COMPOSITION

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

8 Sigachi Industries

8 Roquette

6 Microlex e.U

6 Gangwal Chemicals

6 Seppic

6 Actylis

5 Gangwal Healthcare

4 Kerry

2 DFE Pharma

1 Pharmatrans-Sanaq

1 Jai Radhe Sales

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Nanjing Bold Chemical

1 Vasa Pharmachem

1 Rochem International Inc

1 Kima Chemical

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Prachin Chemical

1 BASF

1 Nanjing Well Pharmaceutical

1 SPI Pharma

1 Finar

1 The Dow Chemical Company

1 Ideal Cures Pvt Ltd

EXCIPIENTS BY APPLICATIONS

16 Fillers, Diluents & Binders

15 Solubilizers

13 Thickeners and Stabilizers

11 Direct Compression

8 Co-Processed Excipients

7 Parenteral

7 Disintegrants & Superdisintegrants

6 Controlled & Modified Release

5 Granulation

4 Rheology Modifiers

4 Coating Systems & Additives

3 Emulsifying Agents

3 Film Formers & Plasticizers

3 Topical

2 Chewable & Orodispersible Aids

2 Lubricants & Glidants

2 Taste Masking

2 Surfactant & Foaming Agents

1 API Stability Enhancers

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons